Are drug-pricing changes helping or harming Canadians?

An article published on Feb. 2 argues that the PMPRB, a federal regulatory agency, must push ahead with reforms to the pricing of pharmaceutical drugs, despite pressure from Big Pharma.

A critical reply instead argues that the pricing changes will ultimately harm Canadians.